House Dems call on health agencies to enforce drug-trial reporting laws

One letter asks FDA Commissioner Margaret Hamburg to explain the delays and suggest any changes to the law that could help address the issue. The other, to NIH Director Francis Collins, asks if his agency has "adequate resources and authority" to implement the requirements of the Food and Drug Administration Amendments Act of 2007, which requires publication of a results summary on for all "applicable drug trial(s)" within 12 months of their completion.

The NIH is responsible for maintaining the public database of drug trial results, while the FDA is responsible for enforcing the statutory drug trial reporting requirements.

The law "was enacted in response to similar reporting failures that contributed to dangerous or ineffective drugs remaining on the market far longer than they should have," the letter points out. "The new study suggests this underreporting is continuing today."

The letter was signed by Reps. Henry Waxman (D-Calif.) and Edward MarkeyEdward (Ed) John MarkeyDemocrats search for 51st net neutrality vote Overnight Regulation: Dems claim 50 votes in Senate to block net neutrality repeal | Consumer bureau takes first step to revising payday lending rule | Trump wants to loosen rules on bank loans | Pentagon, FDA to speed up military drug approvals Dems say they have 50 votes in Senate to overrule net neutrality repeal MORE (D-Mass.), the top Democrats on the Energy and Commerce and Natural Resources committees, respectively, and Rep. Diana DeGette (D-Col.), ranking member on the Energy and Commerce oversight subpanel.